Systemic and Ocular Associations of Keratoconus
- PMID: 39494085
- PMCID: PMC11526800
- DOI: 10.1080/17469899.2024.2368801
Systemic and Ocular Associations of Keratoconus
Abstract
Introduction: Keratoconus (KC) is the most prevalent corneal ectasia in the world and its pathogenesis is influenced by both ocular and systemic factors. This review explores the multifaceted associations between keratoconus and systemic health conditions, ocular characteristics, and various other environmental/exogenous factors, aiming to illuminate how these relationships influence the pathophysiology of the disease.
Areas covered: This review will summarize the fundamental attributes of KC, review and discuss the systemic and ocular association of KC including molecular biomarkers, and provide an organized overview of the parallel alterations occurring within various biological pathways in KC.
Expert opinion: Despite the substantial volume of research on keratoconus, the precise etiology of the disease remains elusive. Further studies are necessary to deepen our understanding of this intricate disorder and improve its management.
Keywords: Biomarkers; Cornea; Keratoconus; Ocular; Systemic.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants, or patents received or pending, or royalties.
Figures
Similar articles
-
Artificial intelligence for detecting keratoconus.Cochrane Database Syst Rev. 2023 Nov 15;11(11):CD014911. doi: 10.1002/14651858.CD014911.pub2. Cochrane Database Syst Rev. 2023. PMID: 37965960 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Periocular Vitiligo in Keratoconus: A Case Report and Literature Review.Cureus. 2025 May 23;17(5):e84690. doi: 10.7759/cureus.84690. eCollection 2025 May. Cureus. 2025. PMID: 40546526 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes.Cochrane Database Syst Rev. 2023 May 31;5(5):CD014513. doi: 10.1002/14651858.CD014513. Cochrane Database Syst Rev. 2023. PMID: 37254718 Free PMC article.
Cited by
-
Strategic Management of Descemet's Membrane Perforation During DALK in Advanced Keratoconus.Rom J Ophthalmol. 2024 Oct-Dec;68(4):448-456. doi: 10.22336/rjo.2024.81. Rom J Ophthalmol. 2024. PMID: 39936068 Free PMC article.
-
Molecular Subtype Identification and Potential Drug Prediction Based on Anoikis-Related Genes Expression in Keratoconus.Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):3. doi: 10.1167/iovs.66.2.3. Invest Ophthalmol Vis Sci. 2025. PMID: 39898909 Free PMC article.
-
Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review.Biomedicines. 2025 Feb 5;13(2):365. doi: 10.3390/biomedicines13020365. Biomedicines. 2025. PMID: 40002778 Free PMC article. Review.
References
-
- Shetty R, D’Souza S, Khamar P, et al. Biochemical Markers and Alterations in Keratoconus. Asia Pac J Ophthalmol (Phila). 2020. Dec;9(6):533–540. - PubMed
-
*This review nicely summarizes the alterations and biochemical markers associated with KC.
Grants and funding
LinkOut - more resources
Full Text Sources